🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

5.977.099

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER ⓘ
—
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 1 día
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
14/09/2022 0,7300 USD
14/06/2022 0,7300 USD
14/03/2022 0,7300 USD
14/12/2021 0,7100 USD
14/09/2021 0,7100 USD
14/06/2021 0,7100 USD
12/03/2021 0,7100 USD
14/12/2020 0,6800 USD
14/09/2020 0,6800 USD
11/06/2020 0,6800 USD
12/03/2020 0,6800 USD
12/12/2019 0,6300 USD
12/09/2019 0,6300 USD
13/06/2019 0,6300 USD
14/03/2019 0,6300 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/06/2023 77,00 78,50 76,90 78,45 +0,76% 2,08% 4.920.500
12/06/2023 78,20 78,30 76,81 77,86 -0,33% 1,91% 5.687.100
09/06/2023 77,52 78,40 77,28 78,12 -0,36% 1,44% 6.375.300
08/06/2023 75,76 78,46 75,76 78,40 +3,05% 3,56% 8.860.500
07/06/2023 76,15 76,23 75,12 76,08 -0,16% 1,46% 7.037.500
06/06/2023 78,29 78,43 76,02 76,20 -1,96% 3,08% 5.408.500
05/06/2023 77,82 78,03 77,18 77,72 -0,22% 1,09% 5.744.100
02/06/2023 76,12 77,99 75,80 77,89 +2,20% 2,88% 4.877.200
01/06/2023 77,54 77,54 75,87 76,21 -0,95% 2,15% 5.031.200
31/05/2023 76,62 77,02 76,27 76,94 +0,80% 0,98% 8.073.100
30/05/2023 76,52 76,87 76,01 76,33 -0,99% 1,12% 5.038.500
26/05/2023 78,00 78,62 77,01 77,09 -0,72% 2,06% 5.439.000
25/05/2023 77,47 78,18 76,26 77,65 -1,77% 2,48% 8.118.100
24/05/2023 79,12 79,26 78,14 79,05 +0,60% 1,42% 5.863.900
23/05/2023 78,60 79,56 78,10 78,58 -0,05% 1,86% 4.542.900
22/05/2023 79,30 79,85 78,40 78,62 -0,29% 1,83% 3.559.500
19/05/2023 78,78 79,62 78,65 78,85 +0,82% 1,23% 5.694.300
18/05/2023 78,88 79,05 77,36 78,21 -0,76% 2,14% 5.049.900
17/05/2023 78,15 79,02 77,05 78,81 +0,63% 2,52% 5.506.900
16/05/2023 79,77 79,77 78,16 78,32 -0,08% 2,02% 5.764.300
15/05/2023 78,07 78,40 77,83 78,38 +0,27% 0,73% 2.723.300
12/05/2023 78,77 79,08 77,91 78,17 -0,67% 1,49% 3.519.100
11/05/2023 78,16 78,76 77,45 78,70 +0,76% 1,68% 5.123.500
10/05/2023 78,77 78,84 77,16 78,11 -0,88% 2,13% 5.613.900
09/05/2023 78,31 79,28 78,30 78,80 +0,27% 1,25% 4.546.600
08/05/2023 79,61 79,66 78,13 78,59 -1,45% 1,92% 3.823.400
05/05/2023 78,75 79,83 78,22 79,75 +1,57% 2,04% 4.613.700
04/05/2023 79,61 79,68 78,41 78,52 -1,17% 1,60% 4.564.200
03/05/2023 80,49 80,90 79,12 79,45 -1,23% 2,21% 5.057.400
02/05/2023 81,53 82,04 80,08 80,44 -1,20% 2,40% 5.647.900